Ballentine Partners LLC Acquires 460 Shares of Colgate-Palmolive (NYSE:CL)

Ballentine Partners LLC raised its holdings in Colgate-Palmolive (NYSE:CL) by 2.2% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 21,007 shares of the company’s stock after buying an additional 460 shares during the quarter. Ballentine Partners LLC’s holdings in Colgate-Palmolive were worth $1,910,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also recently bought and sold shares of CL. FMR LLC increased its holdings in Colgate-Palmolive by 65.6% in the 3rd quarter. FMR LLC now owns 6,749,275 shares of the company’s stock valued at $700,642,000 after buying an additional 2,674,807 shares during the period. Barclays PLC increased its holdings in Colgate-Palmolive by 38.7% in the 3rd quarter. Barclays PLC now owns 7,644,189 shares of the company’s stock valued at $793,542,000 after buying an additional 2,132,747 shares during the period. State Street Corp increased its holdings in Colgate-Palmolive by 3.8% in the 3rd quarter. State Street Corp now owns 48,436,276 shares of the company’s stock valued at $5,028,170,000 after buying an additional 1,784,411 shares during the period. Nordea Investment Management AB grew its holdings in shares of Colgate-Palmolive by 32.5% in the 4th quarter. Nordea Investment Management AB now owns 5,091,683 shares of the company’s stock worth $462,121,000 after purchasing an additional 1,247,731 shares during the last quarter. Finally, AQR Capital Management LLC grew its holdings in shares of Colgate-Palmolive by 58.6% in the 2nd quarter. AQR Capital Management LLC now owns 2,416,943 shares of the company’s stock worth $234,540,000 after purchasing an additional 892,706 shares during the last quarter. Institutional investors own 80.41% of the company’s stock.

Insider Buying and Selling

In related news, CFO Stanley J. Sutula III sold 45,410 shares of the stock in a transaction that occurred on Tuesday, November 5th. The stock was sold at an average price of $94.11, for a total transaction of $4,273,535.10. Following the completion of the sale, the chief financial officer now directly owns 36,726 shares of the company’s stock, valued at approximately $3,456,283.86. This represents a 55.29 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. 0.37% of the stock is owned by company insiders.

Colgate-Palmolive Stock Performance

Colgate-Palmolive stock opened at $88.27 on Wednesday. The company has a current ratio of 1.04, a quick ratio of 0.68 and a debt-to-equity ratio of 9.46. Colgate-Palmolive has a 1 year low of $79.69 and a 1 year high of $109.30. The company has a market cap of $72.12 billion, a PE ratio of 25.29, a PEG ratio of 3.62 and a beta of 0.44. The company’s 50-day moving average is $92.13 and its two-hundred day moving average is $97.71.

Colgate-Palmolive Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, February 14th. Stockholders of record on Tuesday, January 21st will be paid a $0.50 dividend. The ex-dividend date is Tuesday, January 21st. This represents a $2.00 dividend on an annualized basis and a dividend yield of 2.27%. Colgate-Palmolive’s dividend payout ratio (DPR) is presently 57.31%.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently weighed in on the stock. Barclays lowered their target price on shares of Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating on the stock in a report on Friday, January 17th. Stifel Nicolaus lowered their target price on shares of Colgate-Palmolive from $101.00 to $95.00 and set a “hold” rating on the stock in a report on Friday, January 17th. UBS Group lowered their target price on shares of Colgate-Palmolive from $112.00 to $104.00 and set a “buy” rating on the stock in a report on Thursday, January 16th. Wells Fargo & Company lowered their target price on shares of Colgate-Palmolive from $92.00 to $83.00 and set an “underweight” rating on the stock in a report on Tuesday, January 7th. Finally, TD Cowen lowered their target price on shares of Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating on the stock in a report on Wednesday, January 8th. One equities research analyst has rated the stock with a sell rating, ten have given a hold rating and twelve have issued a buy rating to the company. Based on data from MarketBeat.com, Colgate-Palmolive has an average rating of “Hold” and an average price target of $101.11.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.